-- 
Pluristem Rises on Results of Stem Cell Animal Study

-- B y   S h o s h a n n a   S o l o m o n
-- 
2011-09-07T14:18:44Z

-- http://www.bloomberg.com/news/2011-09-07/pluristem-rises-on-results-of-stem-cell-animal-study.html
Pluristem Therapeutics Inc. (PSTI)  rose the
most in almost two weeks after the cell-therapy company said
initial animal studies suggest its cells can increase survival
rates following exposure to lethal doses of radiation.  The shares jumped 7.4 percent, the most since Aug. 25, to
9.474 shekels at the 4:30 p.m. close on the  Tel Aviv  Stock
Exchange. The stock has soared 70 percent this year, giving the
Haifa, Israel-based company a market value of 402 million
shekels ($109 million).  To contact the reporter on this story:
Shoshanna Solomon in Tel Aviv at 
 ssolomon21@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  